Identifying Lifestyle Factors Linked to Colorectal and Breast Cancer in Nigeria
Compares diet, activity and body measures in people with these cancers and people without.
Plain-language title generated from the registry record
Registry title: Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
Key facts
- Where
- Ile-Ife, NigeriaSee the site
Where in Nigeria
- Obafemi Awolowo University Teaching HospitalsIle-Ife, NigeriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Obafemi Awolowo University Teaching Hospital
- Trial code
- NCT05044689
- Record updated
- 21 March 2025
- Original description
This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.Read full original descriptionShow less
Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.
Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.
Case Group - Patients must have histologically confirmed diagnosis of colorectal or breast cancer; Control Group - Patients must not have a diagnosis of cancer.